
    
      To determine if the study is feasible, we will examine the change in patient perception of
      pharmacogenomics testing (before and after the study), the percentage of patients interested
      in this service, the response rate of providers to pharmacist recommendations, the pharmacist
      time requirement, and reimbursement rate for pharmacist services.
    
  